Drug Information

HIBSAGO

Uses

WARNINGS

What is the most important information I should know about HIBSAGO?

HIBSAGO may cause serious side effects, including:

•     flare-ups in liver enzyme levels during treatment. HIBSAGO may cause increases in liver function blood tests.

Tell your healthcare provider right away if you get any of these symptoms:

o   upper right stomach pain                                          o nausea or vomiting

o   dark or “tea-colored” urine                                       o loss of appetite

o   yellowing of your skin or the white part of your eyes

 

•     low platelet counts (thrombocytopenia). HIBSAGO may cause your blood platelet levels to drop at any time during your treatment. When your platelet count is too low, your body cannot form blood clots properly. Low platelet

counts can happen suddenly and without warning and can be life-threatening. Stop using HIBSAGO and tell your healthcare provider right away if you get any of these symptoms:

o   unusual bruising or a rash of tiny reddish-purple spots         o abnormal or heavy periods (menstrual bleeding)

o   bleeding from skin cuts that does not stop or oozes  o sudden severe headaches or neck stiffness

o   bleeding from your gums or nose                              o bleeding into the whites of your eyes

o   blood in your urine or stools

Your healthcare provider will do blood tests to check your liver and platelet count, before you start HIBSAGO, during treatment, and if you have abnormal blood tests for up to 24 weeks after you stop HIBSAGO.

 

It is important that you make sure you get these blood tests done. 

Who should not use HIBSAGO?    Do not use HIBSAGO if you have:

•     a condition where your liver is currently not working as well as it should

•     have advanced liver disease (cirrhosis)

•     low platelet blood counts.

 

Talk to your healthcare provider if you are not sure if you have any of these conditions.

Before using HIBSAGO, tell your healthcare provider about all of your medical conditions, including if you:

•     have bleeding problems or a history of bleeding problems

•     have kidney problems

•     have received an organ transplant

•     have problems with your immune system (autoimmune disease), or have a history of blood vessel inflammation (vasculitis)

•     have hepatitis D

•     are pregnant or plan to become pregnant. It is not known if HIBSAGO will harm your unborn baby.

•     are breastfeeding or plan to breastfeed. HIBSAGO may pass into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with HIBSAGO.

 

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using HIBSAGO with certain other medicines may increase the risk of side effects. Especially tell your healthcare provider if you take:

medicines that prevent your blood from clotting or that lower your blood platelet count.

•     medicines that may lower your kidney function.

•     peginterferon alfa-2a.

Know the medicines you take. Keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

 

USES

What is HIBSAGO?

HIBSAGO is a prescription medicine used with other medicines called nucleos(t)ide analog reverse transcriptase inhibitors (NrtIs), to treat adults with chronic (long-term) hepatitis B virus (HBV) infection without advanced liver disease (cirrhosis):

•     who have been on NrtI treatment for at least 6 months and have undetectable HBV deoxyribonucleic acid (DNA), and

•     who have low levels of HBV surface antigen (HBsAg less than or equal to 3,000 IU/mL) Your healthcare provider will perform tests to make sure HIBSAGO is right for you.

It is not known if HIBSAGO is safe and effective in children less than 18 years of age.

It is not known if HIBSAGO is safe and effective in people who also have hepatitis C virus (HCV) or hepatitis D virus (HDV) infection. HIBSAGO is not recommended in people with HDV infection as it may increase the chance of flare-ups in liver enzymes.

 

HOW TO USE

How should I use HIBSAGO?

Read the detailed Instructions for Use that comes with your HIBSAGO for information on how to inject a dose of HIBSAGO.

•      Use HIBSAGO exactly as your healthcare provider tells you to.

•      Treatment with HIBSAGO usually lasts 24 weeks. Do not take HIBSAGO for longer than 24 weeks.

•      HIBSAGO must be used in combination with NrtI treatment. You must remain on NrtI treatment for at least 24 weeks after stopping treatment with HIBSAGO. Your healthcare provider will decide if you can stop your Nrtl treatment.

•      You will receive your first dose of HIBSAGO under the guidance and supervision of your healthcare provider.

HIBSAGO is given as an injection under the skin (subcutaneous).

•      Your healthcare provider will decide if you or your caregiver may inject HIBSAGO.

o   Your healthcare provider will show you or your caregiver how to inject HIBSAGO.

o   Your healthcare provider will tell you how much HIBSAGO to inject and when to inject it. Do not inject more than

your prescribed dose.

•     Your prescribed dose will generally require two injections. Your healthcare provider will do blood tests during your treatment with HIBSAGO and may decrease your dose to one injection, temporarily stop, or permanently stop your HIBSAGO treatment depending on the results.

o   If your dose is 300 mg, you will need to inject two HIBSAGO prefilled syringes.

o   If your dose is 150 mg, you will need to inject one HIBSAGO prefilled syringe. For a 150 mg dose, keep the

second syringe in the carton and away from light.

The recommended dosing schedule is shown in the table below. Your healthcare provider may tell you to reduce or temporarily stop doses based on your blood tests or how you are feeling. Follow your healthcare provider’s instructions on how to use HIBSAGO.

 

•      Where possible, give each dose on the same day(s) each week.

•      If you miss a dose, and your next dose is in 3 days or more:

o   inject the missed dose as soon as you remember. Then continue your treatment as before.

•      If you miss a dose, and your next dose is in less than 3 days:

o   skip the missed dose and inject the dose at your usual time. Then continue your treatment as before.

•      If you take too much HIBSAGO, call your healthcare provider or the Poison Help line at 1-800-222-1222 or go to the nearest hospital emergency room right away.

After you finish your treatment with HIBSAGO, do not stop taking your NrtI treatment unless your healthcare provider tells you to. If you stop taking NrtI treatment, your HBV may return. It is important that you make sure you still get blood tests done. If you also have human immunodeficiency virus (HIV) and are taking an NrtI as part of your HIV treatment, do not stop the NrtI unless your HIV healthcare provider has told you to stop.

Taking HIBSAGO does not stop you from passing HBV to others. You should continue to practice safety habits to stop from passing HBV to other people.

Side effects

What are the possible side effects of HIBSAGO?

HIBSAGO may cause serious side effects, including:

•      Increased liver laboratory tests: See “What is the most important information I should know about HIBSAGO?”

•      Bleeding because of low platelet counts: See “What is the most important information I should know about HIBSAGO?”

•      Worsening kidney function. Your healthcare provider will do blood tests to check your kidneys before and during treatment, and for up to 12 weeks after you stop HIBSAGO if you have abnormal kidney function blood tests.

It is important that you make sure you get these blood tests done.

•      Inflammatory or immune system problems. Tell your healthcare provider if you get any of these symptoms:

o   flu-like symptoms                                              o    swelling and itchiness

o   purple rashes or spots on the legs

o   scaley, raised or red patches                              o    joint pain that does not go away by itself

•      Serious side effects when HIBSAGO is not injected correctly.

o   Make sure the injection sites are changed (rotated) from one week to the next and that the two injections given weekly are separated by at least 2 inches (5 cm).

o   Do not give injections into areas where the skin is tender, bruised, red, or hard.

The most common side effects of HIBSAGO include:

•        injection site reactions                                   •  tiredness

•        fever                                                                •  headache

Tell your healthcare provider if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of HIBSAGO.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Additional Information

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use HIBSAGO for a condition for which it was not prescribed. Do not give HIBSAGO to other people, even if they have the same symptoms that you have. It may harm them.

 

Throw away (discard) any unused syringes when your healthcare provider tells you that your HIBSAGO treatment is complete.

You can ask your pharmacist or healthcare provider for information about HIBSAGO that is written for health professionals.

 

ACTIVE INGREDIENTS

What are the ingredients in HIBSAGO?

Active ingredient:  epirovirsen sodium

 

Inactive ingredients: water for injection, hydrochloric acid or sodium hydroxide to adjust to pH 8.

 

OVERDOSE

Please call your healthcare provider for more information.

 

MISSED DOSE

Please call your healthcare provider for more information.

 

STORAGE

How should I store HIBSAGO?

•      Store HIBSAGO at room temperature up to 86°F (30°C) for up to 12 weeks.

•      Do not freeze HIBSAGO.

•      Store HIBSAGO in the original carton to protect from light.

•      Throw away (discard) HIBSAGO in an FDA-cleared sharps disposal container after if the expiration date has passed, or it has been 12 weeks since you received your carton, whichever comes first.

•      HIBSAGO must be injected within 6 hours after you remove it from the carton. If the HIBSAGO syringes are not used within 6 hours, throw them away.

 Keep HIBSAGO and all medicines out of the reach of children.

 

NOTES

Medication Guide: revision date 10/2026

Prescribing Information: revision date 10/2026

Interactions

1.) Anticoagulants, Antiplatelets, and Drugs that Decrease Platelet Count

Monitor patients for signs of bleeding and thrombocytopenia if HIBSAGO is taken concomitantly with anticoagulants, antiplatelets, or drugs that decrease platelet count [see the sections WARNINGS and PRECAUTIONS].

2.) Drugs that Impair Renal Function

Monitor patients for signs of worsening renal function during concomitant administration of HIBSAGO with drugs that may impair renal function. Refer to individual drug information before prescribing [see the sections WARNINGS and PRECAUTIONS].

3.) Peginterferon Alfa-2a

Concomitant administration of HIBSAGO and peginterferon alfa-2a is not recommended due to the potential for an exacerbated risk of increased ALT, decreased platelet count, and immune-mediated effects.

Precautions

See the section WARNINGS above.